Skip to main content
Astellas Pharma Inc. (TYO: 4503)
Japan flag Japan · Delayed Price · Currency is JPY
1,542.50
+22.50 (1.48%)
Dec 20, 2024, 3:45 PM JST

Astellas Pharma Revenue

Astellas Pharma had revenue of 462.50B JPY in the quarter ending September 30, 2024, with 17.94% growth. This brings the company's revenue in the last twelve months to 1.77T, up 16.32% year-over-year. In the fiscal year ending March 31, 2024, Astellas Pharma had annual revenue of 1.60T with 5.60% growth.

Revenue (ttm)
1,772.16B
Revenue Growth
+16.32%
P/S Ratio
1.56
Revenue / Employee
120.11M
Employees
14,754
Market Cap
2,761.24B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 20241,603.67B85.05B5.60%
Mar 31, 20231,518.62B222.46B17.16%
Mar 31, 20221,296.16B46.64B3.73%
Mar 31, 20211,249.53B-51.32B-3.94%
Mar 31, 20201,300.84B-5.51B-0.42%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Astellas Pharma News

More News